Gapping up
In reaction to earnings/guidance:
- CHWY +16.5%, VEEV +9%, PSTG +5.2%, NTAP +4.9% (also authorizes addiitonal $1 bln share repurchase program), JWN +3.3%, PHR +2%, HRL +1.7%, CRDO +1.3%, CONN +1%, SPTN +0.9%
Other news:
- AMRN +6% (commercial partner in China EddingPharm has received regulatory approval for VASCEPA)
- MSA +5% (names new COO)
- OB +4.8% (cuts workforce by 10%)
- CLLS +4.2% (announces publication of artcile on UCART20x22)
- DHT +2.5% (acquires vessel)
- HIW +2.5% (announces non-core asset sales of $40.2 mln)
- NRG +2% (entered into a definitive agreement to sell its 44% equity interest in South Texas Project Electric Generating Station to Constellation Energy (CEG) for a purchase price of $1.75 bln)
- SLDP +1.4% (names new CEO)
- ZIP +1.3% (to reduce headcount by 270; reaffirms guidance)
Analyst comments:
- AYX +5% (upgraded to Buy from Neutral at BofA Securities)
- DPZ +2.1% (upgraded to Overweight from Neutral at JP Morgan)
- MDU +1.6% (upgraded to Buy from Underperform at BofA Securities)
- CSX +1.5% (upgraded to Buy from Neutral at UBS)
- IFS +1.2% (upgraded to Overweight from Neutral at JP Morgan)